Netherlands Organization for Applied Scientific Research (TNO), Expertise Group Child Health, Leiden, Netherlands.
Radboud University Medical Center, Radboud Institute for Health Sciences, Primary and Community Care, Nijmegen, Netherlands.
JMIR Form Res. 2024 Oct 30;8:e56390. doi: 10.2196/56390.
Since December 2019, COVID-19 led to a pandemic causing many hospitalizations and deaths. Vaccinations were developed and introduced to control viral transmission. In the Dutch context, the decision to accept vaccination is not mandatory. An informed decision is based on sufficient and reliable information, in line with one's attitudes and values, and with consideration of pros and cons. To support people in informed decision-making, we developed an online COVID-19 vaccination decision aid (DA).
This article aims to describe the development, dissemination, and use of the DA.
Building on a previously developed DA, the COVID-19 vaccination DA was developed in 3 phases following a user-centered design approach: (1) definition phase, (2) concept testing, and (3) prototype testing. End users, individuals with low literacy, and experts (with relevant expertise on medical, behavioral, and low literacy aspects) were involved in the iterative development, design, and testing, with their feedback forming the basis for adaptations to the DA.
The DA was developed within 14 weeks. The DA consists of 3 modules, namely, Provide Information, Support Decision-Making, and Facilitate Actions Following a Decision. These modules are translated into various information tiles and diverse functionalities such as a knowledge test, a value clarification tool using a decisional balance, and a communication tool. The DA was disseminated for use in May 2021. Users varied greatly regarding age, gender, and location in the Netherlands.
This paper elaborates on the development of the COVID-19 vaccination DA in a brief period and its dissemination for use among Dutch adults in the Netherlands. The evaluation of use showed that we were able to reach a large proportion and variety of people throughout the Netherlands.
自 2019 年 12 月以来,COVID-19 引发了一场大流行,导致许多人住院和死亡。疫苗的开发和引入是为了控制病毒的传播。在荷兰,接种疫苗的决定并非强制性的。知情决策是基于充分和可靠的信息,符合个人的态度和价值观,并考虑到利弊。为了支持人们做出明智的决策,我们开发了一个在线 COVID-19 疫苗接种决策辅助工具(DA)。
本文旨在描述该 DA 的开发、传播和使用情况。
基于之前开发的 DA,该 COVID-19 疫苗接种 DA 是按照用户为中心的设计方法分 3 个阶段开发的:(1)定义阶段;(2)概念测试;(3)原型测试。最终用户、低识字率人群和专家(具有医学、行为和低识字率方面的相关专业知识)参与了迭代开发、设计和测试,他们的反馈为 DA 的调整提供了依据。
DA 在 14 周内完成开发。DA 由 3 个模块组成,分别是提供信息、辅助决策和决策后促进行动。这些模块被转化为各种信息模块和不同的功能,如知识测试、使用决策平衡表的价值观澄清工具和沟通工具。该 DA 于 2021 年 5 月开始传播使用。用户在年龄、性别和荷兰地理位置方面差异较大。
本文简要阐述了 COVID-19 疫苗接种 DA 的快速开发及其在荷兰成年人中的传播和使用。使用情况的评估表明,我们能够覆盖到荷兰各地的大量人群,且人群类型多样。